Global Drug Delivery Technologies Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 - 2025

  • ID: 4394903
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • 3M Company
  • Antares Pharma, Inc.
  • Bayer AG
  • Hoffmann La-Roche
  • Johnson & Johnson
  • Novartis AG
  • MORE

The drug delivery technologies market was valued at USD 200.2 Bn in 2017, and is expected to reach USD 297.35 Bn by 2025, expanding at a CAGR of 6.9% from 2017 - 2025.

Market Insights

Patent expiry of several major drugs, coupled with the expensive business of development of new chemical entity has posed as a prime concern for pharmaceutical manufacturers. Development of new chemical entity is often observed to be a more expensive affair than development of novel delivery technology. Hence, several pharmaceutical manufacturers have adopted new drug delivery technologies for their portfolio as an effective life cycle management strategy.

The global drug delivery devices market is studied for mode of administration and geography segmentations. Oral, pulmonary, transdermal, injectable, nasal, implantable, and ocular, buccal etc. cumulatively make the drug delivery technologies market. Among these, oral drug delivery is the largest segment, followed by pulmonary drug delivery in 2015 at a combined market share of over 65%.

Newer technologies through products such as orodispersible tablets, transdermal patches, pen injectors, powder inhalers and buccal tablets are among the most widely adopted products. Additionally, the demand for drug eluting implants is also on a continuous rise in the developed markets. Implantable drug delivery devices find application in diabetes management, contraception, cardiology, pain management, pain management and others.

Geographically, North America is the largest regional market for drug delivery technologies. Well structured reimbursement policies, large scale adoption of latest technologies, high prevalence of chronic diseases and high level of awareness among both care givers and patients are the prime contributors to the growth of North America drug delivery technologies market. In terms of growth rate, Asia-Pacific and Latin America are the fastest developing markets for drug delivery technologies. Fast developing healthcare infrastructure, gradually rising awareness and improving healthcare expenditure supplement the growth of emerging markets.

Intense competition among drug manufacturers to manage product life cycles of blockbuster drugs, and rising trend of manufacturing outsourcing have made the drug delivery technologies market fragmented. Merck, 3M Company, Johnson and Johnson, Becton Diskinson and Company and others are some of the major players in the global drug delivery technologies market.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3M Company
  • Antares Pharma, Inc.
  • Bayer AG
  • Hoffmann La-Roche
  • Johnson & Johnson
  • Novartis AG
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Drug Delivery Technologies Market, 2015-2025 (USD Bn)
2.2 Drug Delivery Technologies Market Share, by Mode of Administration, 2015 & 2022 (Value %)
2.3 Drug Delivery Technologies Market Share, by Geography, 2015 (Value %)

Chapter 3 Global Drug Delivery Technologies Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.2 Drivers
3.3 Challenges
3.4 Future Prospects
3.5 Fractal Map Analysis: by Key Market Players
3.6 Attractive Investment Proposition

Chapter 4 Global Drug Delivery Technologies Market Analysis, by Mode of Administration
4.1 Preface
4.2 Oral
4.3 Pulmonary
4.3.1 Pulmonary Drug Delivery Technology Market, 2015 - 2025 (USD Bn)
4.4 Transdermal
4.4.1 Transdermal Drug Delivery Technology Market, 2015-2025 (USD Bn)
4.5 Injectable
4.5.1 Injectable Drug Delivery Technology Market, 2015-2025 (USD Bn)
4.6 Nasal
4.6.1 Nasal Drug Delivery Technology Market, 2015-2025 (USD Bn)
4.7 Implantable
4.7.1 Implantable Drug Delivery Technology Market, 2015-2025 (USD Bn)
4.8 Others (Ocular, Buccal, Etc.)
4.8.1 Other Drug Delivery Technologies Market, 2015-2025 (USD Bn)

Chapter 5 Drug Delivery Technologies Market, by Geography
5.1 Preface
5.2 North America
5.2.1 North America Drug Delivery Technologies Market, by Country, 2015 - 2025 (USD Bn)
5.2.2 U.S. Drug Delivery Technologies Market, 2015-2025 (USD Bn)
5.2.3 Canada Drug Delivery Technologies Market, 2015-2025 (USD Bn)
5.3 Europe
5.3.1 Europe Drug Delivery Technologies Market, by Country, 2015 - 2025 (USD Bn)
5.3.2 U.K. Drug Delivery Technologies Market, 2015-2025 (USD Bn)
5.3.3 Germany Drug Delivery Technologies Market, 2015-2025 (USD Bn)
5.3.4 Rest of Europe Drug Delivery Technologies Market, 2015-2025 (USD Bn)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Drug Delivery Technologies Market, by Country, 2015 - 2025 (USD Bn)
5.4.2 Japan Drug Delivery Technologies Market, 2015-2025 (USD Bn)
5.4.3 China Drug Delivery Technologies Market, 2015-2025 (USD Bn)
5.4.4 Rest of Asia-Pacific Drug Delivery Technologies Market, 2015-2025 (USD Bn)
5.5 Middle East and Africa (MEA)
5.5.1 Middle East and Africa Drug Delivery Technologies Market, 2015 - 2025 (USD Bn)
5.6 Latin Ameirca
5.6.1 Latin America Drug Delivery Technologies Market, 2015-2025 (USD Bn)

Chapter 6 Company Profiles
6.1 Bayer AG
6.1.1 Business Description
6.1.2 Financial Health and Budget Allocation
6.1.3 Product Positions/Portfolio
6.1.4 News Coverage
6.2 Becton, Dickinson and Company
6.2.1 Business Description
6.2.2 Financial Health and Budget Allocation
6.2.3 Product Positions/Portfolio
6.2.4 News Coverage
6.3 3M Company
6.3.1 Business Description
6.3.2 Financial Health and Budget Allocation
6.3.3 Product Positions/Portfolio
6.3.4 News Coverage
6.4 Antares Pharma, Inc.
6.4.1 Business Description
6.4.2 Financial Health and Budget Allocation
6.4.3 Product Positions/Portfolio
6.4.4 News Coverage
6.5 Johnson & Johnson
6.5.1 Business Description
6.5.2 Financial Health and Budget Allocation
6.5.3 Product Positions/Portfolio
6.5.4 News Coverage
6.6 Novartis AG
6.6.1 Business Description
6.6.2 Financial Health and Budget Allocation
6.6.3 Product Positions/Portfolio
6.6.4 News Coverage
6.7 Pfizer, Inc.
6.7.1 Business Description
6.7.2 Financial Health and Budget Allocation
6.7.3 Product Positions/Portfolio
6.7.4 News Coverage
6.8 F. Hoffmann La-Roche
6.8.1 Business Description
6.8.2 Financial Health and Budget Allocation
6.8.3 Product Positions/Portfolio
6.8.4 News Coverage
6.9 Sanofi
6.9.1 Business Description
6.9.2 Financial Health and Budget Allocation
6.9.3 Product Positions/Portfolio
6.9.4 News Coverage
6.10 Other Notable Players

List of Figures
Fig. 1 Drug Delivery Technologies: Market Segmentation
Fig. 2 Drug Delivery Technologies Market, 2015 - 2025 (USD Bn)
Fig. 3 Drug Delivery Technologies Market Share, by Mode of Administration, 2015 & 2022 (Value %)
Fig. 4 Drug Delivery Technologies Market Share, by Geography, 2015 (Value %)
Fig. 5 Fractal Map Analysis: by Key Market Players
Fig. 6 Attractive Investment Proposition, Drug Delivery Technologies Market, 2015
Fig. 7 Oral Drug Delivery Technology Market, 2015 - 2025 (USD Bn)
Fig. 8 Pulmonary Drug Delivery Technology Market, 2015 - 2025 (USD Bn)
Fig. 9 Transdermal Drug Delivery Technology Market, 2015 - 2025 (USD Bn)
Fig. 10 Injectable Drug Delivery Technology Market, 2015 - 2025 (USD Bn)
Fig. 11 Nasal Drug Delivery Technology Market, 2015 - 2025 (USD Bn)
Fig. 12 Implantable Drug Delivery Technology Market, 2015 - 2025 (USD Bn)
Fig. 13 Other Drug Delivery Technologies Market, 2015 - 2025 (USD Bn)
Fig. 14 U.S. Drug Delivery Technologies Market, 2015 - 2025 (USD Bn)
Fig. 15 Canada Drug Delivery Technologies Market, 2015 - 2025 (USD Bn)
Fig. 16 U.K. Drug Delivery Technologies Market, 2015 - 2025 (USD Bn)
Fig. 17 Germany Drug Delivery Technologies Market, 2015 - 2025 (USD Bn)
Fig. 18 Rest of Europe Drug Delivery Technologies Market, 2015 - 2025 (USD Mn Bn)
Fig. 19 Japan Drug Delivery Technologies Market, 2015 - 2025 (USD Bn)
Fig. 20 China Drug Delivery Technologies Market, 2015 - 2025 (USD Bn)
Fig. 21 Rest of Asia-Pacific Drug Delivery Technologies Market, 2015 - 2025 (USD Bn)
Fig. 22 Middle East and Africa Drug Delivery Technologies Market, 2015 - 2025 (USD Bn)
Fig. 23 Latin America Drug Delivery Technologies Market, 2015 - 2025 (USD Bn)

List of Tables
Table 1 Global Drug Delivery Technologies Market, by Mode of Administration, 2015-2025 (USD Bn)
Table 2 Global Drug Delivery Technologies Market, by Geography, 2015 - 2025 (USD Bn)
Table 3 North America Drug Delivery Technologies Market, by Country, 2015 - 2025 (USD Bn)
Table 4 Europe Drug Delivery Technologies Market, by Country, 2015 - 2025 (USD Bn)
Table 5 Asia-Pacific Drug Delivery Technologies Market, by Country, 2015 - 2025 (USD Bn)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Bayer AG
  • Becton, Dickinson and Company
  • 3M Company
  • Antares Pharma, Inc.
  • Johnson & Johnson
  • Novartis AG
  • Pfizer, Inc.
  • Hoffmann La-Roche
  • Sanofi
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll